TVARDI THERAPEUTICS, INC. Restricted Cash and Cash Equivalents, Noncurrent
TVARDI THERAPEUTICS, INC. (TVRD) had Restricted Cash and Cash Equivalents, Noncurrent of $769.00 thousand as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2018-05-09
- 2018-03-31: Restricted Cash and Cash Equivalents, Noncurrent $769.00K.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $769.00K.
- 2017-09-30: Restricted Cash and Cash Equivalents, Noncurrent $769.00K.
- 2017-06-30: Restricted Cash and Cash Equivalents, Noncurrent $769.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2018-03-31 | $769.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $769.00K 10-Q · filed 2018-05-09 |
| 2017-09-30 | $769.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $769.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $769.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $769.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $1.47M 10-Q · filed 2016-11-04 |
| 2015-12-31 | $700.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |